Compounds that demonstrate clear efficacy in rat tendon healing studies have repeatedly failed to reproduce those effects in human clinical trials this is a documented pattern across pharmaceutical development, not a theoretical concern
Recently, Pfizer also successfully secured the ownership of GLP-1 biotechnology company Metsera after a surprise bidding conflict, adding Metseras injectable asset, MET-097i (which is in Phase 2b testing and has the potential for once-a-month dosing), to its portfolio
These medications are powerful metabolic agents
Cofactor of several antioxidant enzymes Mast cell stabilization Regeneration of vitamins C and E Decrease incidents of muscle damage Boosting strength and endurance Encourages the body to make more muscle than fat Reduces exercise and injury recovery times Detoxifies the liver, even in conditions like fatty liver disease Side Effects of Glutathione: Some people may experience flu-like side effects such as chills, headache, and nausea
Researchers have linked Breast Colorectal Endometrial Esophageal Gallbladder Kidney Liver Meningioma (a type of brain tumor) Multiple myeloma (a type of bone marrow cancer) Ovarian Pancreatic Stomach (gastric) Thyroid Between December 2014 and June 2025, 38% of study participants received a GLP-1 prescription, and the remaining 62% received diet and exercise counseling